Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jian Zhang
Fudan University
Principal Investigator - Jiong Wu
Fudan University
Principal Investigator - Yongmei Yin
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jiangsu Province Hospital
Nanjing, Jiangsu, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Sept 2023
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2025
- Last update posted
- 29 Nov 2024
- Registered enrollment
- 168
- Registry id
- NCT06143553
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.